ATRI Key Statistics, Chart & Performance
The current stock price of ATRI is 459.92 USD. In the past month the price increased by 0.48%. In the past year, price increased by 0.88%.
ATRI Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to ATRI. When comparing the yearly performance of all stocks, ATRI is a bad performer in the overall market: 67.28% of all stocks are doing better.
ATRI Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to ATRI. While ATRI has a great health rating, its profitability is only average at the moment.
ATRI Financial Highlights
Over the last trailing twelve months ATRI reported a non-GAAP Earnings per Share(EPS) of 7.13. The EPS decreased by -53.54% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 6.92% | ||
| ROA | 4.82% | ||
| ROE | 5.26% | ||
| Debt/Equity | 0 |
ATRI Forecast & Estimates
ATRI Ownership
ATRI Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| COO | COOPER COS INC/THE | 18 | 15.925B | ||
| SOLV | SOLVENTUM CORP | 12.05 | 13.352B | ||
| ALGN | ALIGN TECHNOLOGY INC | 16.75 | 12.601B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 19.99 | 4.721B | ||
| LNTH | LANTHEUS HOLDINGS INC | 11.44 | 4.301B | ||
| ICUI | ICU MEDICAL INC | 18.79 | 3.695B | ||
| HAE | HAEMONETICS CORP/MASS | 10.81 | 3.044B | ||
| XRAY | DENTSPLY SIRONA INC | 8.69 | 2.5B | ||
| NEOG | NEOGEN CORP | 32.33 | 2.301B | ||
| UFPT | UFP TECHNOLOGIES INC | 26.67 | 1.975B |
Related stock screener links
View all stocks in the Health Care Supplies Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About ATRI
Company Profile
Atrion Corp. engages in the manufacture and development of products for medical applications. The company is headquartered in Allen, Texas and currently employs 712 full-time employees. The firm's medical products are used in a number of fields including fluid delivery, cardiovascular, and ophthalmic applications. The company has developed a variety of proprietary valves designed to precisely fill, hold, and release and/or remove controlled amounts of fluids, including blood and drugs, or gasses on demand for use in areas such as intubation, intravenous, catheter, and other applications in fields including anesthesia and oncology. The core of its cardiovascular products is its Myocardial Protection System, a technology that is the only open-heart surgery system that delivers to the heart essential fluids and medications, mixes critical drugs, and controls temperature, pressure, and other important variables. The firm also manufactures a line of balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults.
Company Info
ATRION CORPORATION
One Allentown Parkway
Allen TEXAS 75002 US
CEO: David A. Battat
Employees: 712
Phone: 19723909800
ATRION CORPORATION / ATRI FAQ
What does ATRION CORPORATION do?
Atrion Corp. engages in the manufacture and development of products for medical applications. The company is headquartered in Allen, Texas and currently employs 712 full-time employees. The firm's medical products are used in a number of fields including fluid delivery, cardiovascular, and ophthalmic applications. The company has developed a variety of proprietary valves designed to precisely fill, hold, and release and/or remove controlled amounts of fluids, including blood and drugs, or gasses on demand for use in areas such as intubation, intravenous, catheter, and other applications in fields including anesthesia and oncology. The core of its cardiovascular products is its Myocardial Protection System, a technology that is the only open-heart surgery system that delivers to the heart essential fluids and medications, mixes critical drugs, and controls temperature, pressure, and other important variables. The firm also manufactures a line of balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults.
What is the current price of ATRI stock?
The current stock price of ATRI is 459.92 USD. The price increased by 0.06% in the last trading session.
Does ATRION CORPORATION pay dividends?
ATRION CORPORATION (ATRI) has a dividend yield of 1.91%. The yearly dividend amount is currently 8.6.
What is the ChartMill technical and fundamental rating of ATRI stock?
ATRI has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
What is ATRION CORPORATION worth?
ATRION CORPORATION (ATRI) has a market capitalization of 809.46M USD. This makes ATRI a Small Cap stock.
When does ATRION CORPORATION (ATRI) report earnings?
ATRION CORPORATION (ATRI) will report earnings on 2024-11-05, after the market close.